# Rapid Evaluation of Amantadine for Treatment of Cocaine Abuse/Dependence - 4

> **NCT00000301** · PHASE2 · COMPLETED · sponsor: **University of California, Los Angeles**

## Conditions studied

- Cocaine-Related Disorders

## Interventions

- **DRUG:** Amantadine

## Key facts

- **NCT ID:** NCT00000301
- **Lead sponsor:** University of California, Los Angeles
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1996-03
- **Primary completion:** 1998-06
- **Final completion:** —
- **Target enrollment:** 0 (—)
- **Last updated:** 2016-07-11

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00000301

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00000301, "Rapid Evaluation of Amantadine for Treatment of Cocaine Abuse/Dependence - 4". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00000301. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*